Among the U.S. Food and Drug Administration's responsibilities are approval and regulation of pharmaceutical drugs. In short, its responsibility is to ensure the safety and effectiveness of drugs. In the performance of this task, FDA officials can make two types of errors — statistically known as the type I error and type II error. With respect to the FDA, a type I error is the rejection or delayed approval of a drug that is safe and effective — erring on the side of over-caution -- and a type II error is the approval of a drug that has unanticipated dangerous side effects, or erring on the side of under-caution.
In a display of irresponsibility on Thursday night, MSNBC’s Hardball panel predicted with hints of approval that “Leninist” President Trump will be to blame if disease outbreaks or terror attacks occur on U.S. soil during his presidency should he shrink the size of government spending and federal bureaucracy.
Networks vilified a drug company and its CEO for the high price of life-saving allergy medicine, all while ignoring government actions which enabled the company’s monopoly, contributed to rising costs and increased demand. Democratic presidential nominee Hillary Clinton blasted Mylan Pharmaceuticals on Aug. 24, for raising the price of a life-saving medical device called EpiPen by 480 percent in recent years.
In spite of CDC statistics documenting the dramatically higher rate of HIV infection among homosexual males in contrast with the general population -- so much so that more than 60 percent of AIDS patients are homosexual men -- CNN host Anderson Cooper and medical correspondent Dr. Sanjay Gupta on Thursday's Anderson Cooper 360 seemed befuddled at why the Obama administration FDA would bar homosexual men from donating blood in the aftermath of the Orlando nightclub terror attack.
"Advocates for abortion rights don’t get a lot of good news, but Wednesday brought some," MSNBC.com's Irin Carmon gleefully opened her March 30 story, "FDA move could radically transform abortion access."
The Obama FDA today changed labeling requirements for use of the RU-486 abortion pill. Noting the revision, the Daily Beast website cheered the move as "progress."
New and expensive federal regulations stemming from Obamacare that will require many restaurants publish calorie counts probably won’t have much impact on patrons’ food choices, experts told The Huffington Post.
The Food and Drug Administration (FDA) announced on November 25 that “chain restaurants, similar retail food establishments and vending machines with 20 or more locations” must post calorie counts on their menus or menu boards. The new rules were required by a provision in the Affordable Care Act.
During their Tuesday evening newscasts, CBS and NBC squeezed in a few moments each to promote the newest health-related regulation set to affect Americans under ObamaCare next year in the form of additional requirements regarding the listing of calories for food and drinks at public eating establishments, vending machines, and movie theaters.
Both networks pointed out that the move was announced and will be overseen by the Food and Drug Administration (FDA), but failed to present any opposition to these changes with NBC neglecting to even mention that the regulations derived from the President’s health care law.
The Food and Drug Administration (FDA) updated its public statement on bisphenol A, a chemical commonly found in some plastics as well as can linings, in March 2013. The FDA’s “current perspective on BPA” is that the chemical is “safe” at the exposure levels from product packaging.